切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2023, Vol. 12 ›› Issue (06) : 608 -612. doi: 10.3877/cma.j.issn.2095-3232.2023.06.004

临床研究

淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响
潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强()   
  1. 100020 首都医科大学附属北京朝阳医院肝胆胰脾外科
  • 收稿日期:2023-07-27 出版日期:2023-12-10
  • 通信作者: 贺强

Effect of number of dissected lymph nodes on efficacy of pancreaticoduodenectomy for distal cholangiocarcinoma

Bing Pan, Shaocheng Lyu, Xin Zhao, Lixin Li, Ren Lang, Qiang He()   

  1. Department of Hepatobiliary, Pancreatic and Spleen Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
  • Received:2023-07-27 Published:2023-12-10
  • Corresponding author: Qiang He
引用本文:

潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.

Bing Pan, Shaocheng Lyu, Xin Zhao, Lixin Li, Ren Lang, Qiang He. Effect of number of dissected lymph nodes on efficacy of pancreaticoduodenectomy for distal cholangiocarcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 608-612.

目的

探讨淋巴结清扫数目对远端胆管癌胰十二指肠切除手术安全性及预后的影响。

方法

回顾性分析2015年1月至2021年12月在首都医科大学附属北京朝阳医院行胰十二指肠切除术的104例远端胆管癌患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男60例,女44例;年龄29~84岁,中位年龄66岁。分析淋巴结清扫数目对患者围手术期并发症及生存预后的影响。采用X-tile软件分析确定淋巴结数目临界值,根据临界值分为两组。两组淋巴结数目比较采用t检验,并发症发生率等比较采用χ2检验。生存分析采用Kaplan-Meier法和Log-rank检验。

结果

患者清扫淋巴结数目3~45个,依据淋巴结数目临界值24个,将患者分为两组,其中淋巴结数目<24个80例和淋巴结清扫数目≥24个24例。<24个组和≥24个组患者清扫出淋巴结数目分别为(15±5)、(31±6)个,差异有统计学意义(t=-13.101,P<0.05);两组患者术后并发症发生率和围手术期死亡率分为21%(5/24)、4%(1/24)和21%(26/80)、5%(4/80),差异无统计学意义(χ2=1.201,0.142;P>0.05);两组患者术后1、3、5年总体生存率分别为72.6%、33.2%、25.9%和87.1%、63.7%、63.7%,差异有统计学意义(χ2=6.170,P<0.05)。

结论

对于远端胆管癌胰十二指肠切除术患者,清扫淋巴结清扫数目≥24个可明显改善生存预后,且不会增加围手术期安全风险。

Objective

To evaluate the effect of the number of dissected lymph nodes on the safety and prognosis of pancreaticoduodenectomy for distal cholangiocarcinoma.

Methods

Clinical data of 104 patients with distal cholangiocarcinoma who underwent pancreatoduodenectomy in Beijing Chaoyang Hospital Affiliated to Capital Medical University from January 2015 to December 2021 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 60 patients were male and 44 female, aged from 29 to 84 years, with a median age of 66 years. The effect of the number of dissected lymph nodes on perioperative complications and survival was evaluated. The threshold value of lymph node number was determined by X-tile software. All patients were divided into two groups according to the threshold value. The number of lymph nodes between two groups was compared by t test, and the incidence of complications was compared by Chi-square test. Survival analysis was performed by Kaplan-Meier method and Log-rank test.

Results

The number of dissected lymph nodes was 3-45. According to the threshold value of 24 lymph nodes, all patients were divided into the <24 (n=80) and ≥24 groups (n=24). The number of dissected lymph nodes in the <24 group and ≥24 group was 15±5 and 31±6, and the difference was statistically significant (t=-13.101, P<0.05). The incidence of postoperative complications and perioperative mortality rate in two groups were 21%(5/24), 4%(1/24) and 21%(26/80), 5%(4/80), and the differences were not statistically significant (χ2=1.201, 0.142; P>0.05). The postoperative 1-, 3- and 5-year overall survival rates of patients in two groups were 72.6%, 33.2%, 25.9% and 87.1%, 63.7%, 63.7%, respectively, and the differences were statistically significant (χ2=6.170, P<0.05).

Conclusions

For patients with distal cholangiocarcinoma undergoing pancreatoduodenectomy, the number of dissected lymph nodes ≥24 can significantly improve clinical prognosis without sacrificing perioperative safety.

表1 不同淋巴结清扫数目远端胆管癌胰十二指肠切除术患者基线资料比较
表2 不同淋巴结清扫数目远端胆管癌胰十二指肠切除术患者围手术期情况比较
图1 不同淋巴结清扫数目远端胆管癌胰十二指肠切除术患者Kaplan-Meier生存曲线注:1为≥24个组,2为<24个组
[1]
任章勇, 吕少诚, 曹迪, 等. 远端胆管腺鳞癌八例诊治分析[J]. 中华普通外科杂志, 2021, 36(10):789-790.
[2]
张永杰, 俞文隆. 胆管癌手术方式的合理选择[J/CD]. 中华肝脏外科手术学电子杂志, 2015, 4(2):73-75.
[3]
Park Y, Hwang DW, Kim JH, et al. Prognostic comparison of the longitudinal margin status in distal bile duct cancer: R0 on first bile duct resection versus R0 after additional resection[J]. J Hepatobiliary Pancreat Sci, 2019, 26(5):169-178.
[4]
关宇, 刘军广, 史继荣, 等. 远端胆管癌根治性胰十二指肠切除术的预后影响因素分析[J]. 解放军医学杂志, 2022, 47(3):237-242.
[5]
吴鹏飞, 张凯, 陆子鹏, 等. 胰十二指肠切除术治疗远端胆管癌和胰头癌的临床效果分析[J]. 中华外科杂志, 2022, 60(2):128-133.
[6]
刘小梯, 毛先海, 杨建辉, 等. 腹腔镜胰十二指肠切除术远端胆管癌根治术自我质控体系建设及应用[J]. 中国普通外科杂志, 2020, 29(6):731-738.
[7]
Lee RM, Maithel SK. Approaches and outcomes to distal cholangiocarcinoma[J]. Surg Oncol Clin N Am, 2019, 28(4):631-643.
[8]
潘冰, 吕少诚, 赵昕, 等. 肝门部胆管癌的外科治疗及预后分析[J]. 国际外科学杂志, 2019, 46(2):84-88.
[9]
Di Martino M, Koh YX, Syn N, et al. It is the lymph node ratio that determines survival and recurrence patterns in resected distal cholangiocarcinoma. a multicenter international study[J]. Eur J Surg Oncol, 2022, 48(7):1576-1584.
[10]
Jung W, Kim K, Min SK, et al. Mapping of local recurrence afterpancreaticoduodenectomy for distal extrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy[J]. Br J Radiol, 2019, 92(1100):20190285.
[11]
Sabater L, Cugat E, Serrablo A, et al. Does the artery-first approach improve the rate of R0 resection in pancreatoduodenectomy?: a multicenter, randomized, controlled trial[J]. Ann Surg, 2019, 270(5):738-746.
[12]
Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging[J]. CA Cancer J Clin, 2017, 67(2):93-99.
[13]
Kang JS, Higuchi R, He J, et al. Proposal of the minimal number of retrieved regional lymph nodes for accurate staging of distal bile duct cancer and clinical validation of the three-tier lymph node staging system (AJCC 8th edition)[J]. J Hepatobiliary Pancreat Sci, 2020, 27(2):75-83.
[14]
Suzuki S, Shimoda M, Shimazaki J, et al. Number of positive lymph nodes and lymphatic invasion are significant prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma[J]. Clin Exp Gastroenterol, 2019(12):255-262.
[15]
Ito K, Ito H, Allen PJ, et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma[J]. Ann Surg, 2010, 251(4):675-681.
[16]
邓文英, 魏辰, 李宁, 等. 食管癌根治术后患者淋巴结转移与预后的关系[J]. 中华医学杂志, 2016, 96(47):3829-3832.
[17]
王芳, 杨建美, 陈建广, 等. 淋巴结清扫数量对pN0期非小细胞肺癌患者预后的影响[J]. 临床肺科杂志, 2022, 27(4):556-561.
[18]
汪金钱, 魏大中, 解明然, 等. 淋巴结清扫数目对无淋巴结转移SiewertⅡ型食管胃交界部腺癌患者预后的影响[J]. 中华肿瘤杂志, 2016, 38(4):300-304.
[19]
Xu S, Zhang XP, Zhao GD, et al. A novel online calculator to predict recurrence risk in patients with distal cholangiocarcinoma after radical pancreaticoduodenectomy[J]. J Surg Oncol, 2022, 125(3):377-386.
[20]
Xu S, Zhang XP, Zhao GD, et al. Development and validation of an online calculator to predict early recurrence and long-term survival in patients with distal cholangiocarcinoma after pancreaticoduodenectomy[J]. J Hepatobiliary Pancreat Sci, 2022, 29(11):1214-1225.
[21]
吕少诚, 贺强, 郎韧, 等. 异体血管置换技术在合并血管侵犯的胰腺癌根治性手术中的应用[J]. 中华外科杂志, 2018, 56(4):274-278.
[22]
Vuorela T, Vikatmaa P, Kokkola A, et al. Long-term results in pancreatectomy with and without venous resection: a comparison of safety and complications in spiral graft, end-to-end and tangential/patch reconstruction techniques[J]. Eur J Vasc Endovasc Surg, 202264(2/3):244-253.
[23]
Lyu S, Wang F, Ren Z, et al. Long-term survival in patients with distal cholangiocarcinoma after pancreaticoduodenectomy combined with portal vein system resection and reconstruction[J]. Langenbecks Arch Surg, 2021, 406(6):1917-1924.
[24]
Kamarajah SK, Bednar F, Cho CS, et al. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: a propensity-matched national cancer database analysis[J]. Cancer, 2021, 127(8):1266-1274.
[1] 应康, 杨璨莹, 刘凤珍, 陈丽丽, 刘燕娜. 左心室心肌应变对无症状重度主动脉瓣狭窄患者的预后评估价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 581-587.
[2] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[3] 燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[4] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[5] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[6] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[7] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[8] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[9] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[10] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[11] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[12] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要